Literature DB >> 20600463

Parent-child DRD4 genotype as a potential biomarker for oppositional, anxiety, and repetitive behaviors in children with autism spectrum disorder.

Kenneth D Gadow1, Carla J DeVincent, Victoria Pisarevskaya, Doreen M Olvet, Wenjie Xu, Nancy R Mendell, Stephen J Finch, Eli Hatchwell.   

Abstract

The primary objective of the present study was to examine whether a combination of parent-child DRD4 genotypes results in more informative biomarkers of oppositional, separation anxiety, and repetitive behaviors in children with autism spectrum disorder (ASD). Based on prior research indicating the 7-repeat allele as a potential risk variant, participants were sorted into one of four combinations of parent-child genotypes. Owing to the possibility of parent-of-origin effects, analyses were conducted separately for mother-child (MC) and father-child (FC) dyads. Mothers completed a validated DSM-IV-referenced rating scale. Partial eta-squared (ηp(2)) was used to determine the magnitude of group differences: 0.01-0.06=small, 0.06-0.14=moderate, and >0.14=large. Analyses indicated that children in MC dyads with matched genotypes had the least (7-/7-) and most (7+/7+) severe mother-rated oppositional-defiant (ηp(2)=0.11) and separation anxiety (ηp(2)=0.19) symptoms. Conversely, youths in FC dyads with matched genotypes had the least (7-/7-) and most (7+/7+) severe obsessive-compulsive behaviors (ηp(2)=0.19) and tics (ηp(2)=0.18). Youths whose parents were both noncarriers had less severe tics than peers with at least one parental carrier, and the effect size was large (ηp(2)=0.16). There was little evidence that noncarrier children were rated more severely by mothers who were carriers versus noncarriers. Transmission Disequilibrium Test analyses provided preliminary evidence for undertransmission of the 2-repeat allele in youths with more severe tics (p=0.02). Parent genotype may be helpful in constructing prognostic biomarkers for behavioral disturbances in ASD; however, findings are tentative pending replication with larger, independent samples.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20600463      PMCID: PMC2939241          DOI: 10.1016/j.pnpbp.2010.06.019

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  82 in total

Review 1.  Neurochemical individuality: genetic diversity among human dopamine and serotonin receptors and transporters.

Authors:  A Cravchik; D Goldman
Journal:  Arch Gen Psychiatry       Date:  2000-12

2.  Some statistical methods for multiple endpoints in clinical trials.

Authors:  J Zhang; H Quan; J Ng; M E Stepanavage
Journal:  Control Clin Trials       Date:  1997-06

3.  Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1.

Authors:  D E Comings; S Wu; C Chiu; R H Ring; R Gade; C Ahn; J P MacMurray; G Dietz; D Muhleman
Journal:  Am J Med Genet       Date:  1996-05-31

4.  Psychiatric disorder and the broad autism phenotype: evidence from a family study of multiple-incidence autism families.

Authors:  J Piven; P Palmer
Journal:  Am J Psychiatry       Date:  1999-04       Impact factor: 18.112

5.  Systems analysis of stress and positive perceptions in mothers and fathers of pre-school children with autism.

Authors:  Richard P Hastings; Hanna Kovshoff; Nicholas J Ward; Francesca degli Espinosa; Tony Brown; Bob Remington
Journal:  J Autism Dev Disord       Date:  2005-10

6.  The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.

Authors:  C Lord; S Risi; L Lambrecht; E H Cook; B L Leventhal; P C DiLavore; A Pickles; M Rutter
Journal:  J Autism Dev Disord       Date:  2000-06

7.  A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia.

Authors:  Y Okuyama; H Ishiguro; M Toru; T Arinami
Journal:  Biochem Biophys Res Commun       Date:  1999-05-10       Impact factor: 3.575

8.  Repetitive behaviour in children with high functioning autism and obsessive compulsive disorder.

Authors:  Fiona Zandt; Margot Prior; Michael Kyrios
Journal:  J Autism Dev Disord       Date:  2007-02

9.  Validation of DSM-IV model of psychiatric syndromes in children with autism spectrum disorders.

Authors:  Luc Lecavalier; Kenneth D Gadow; Carla J DeVincent; Michael C Edwards
Journal:  J Autism Dev Disord       Date:  2008-07-25

Review 10.  Strategy for investigating interactions between measured genes and measured environments.

Authors:  Terrie E Moffitt; Avshalom Caspi; Michael Rutter
Journal:  Arch Gen Psychiatry       Date:  2005-05
View more
  3 in total

1.  Enhancement of gamma activity after selective activation of dopamine D4 receptors in freely moving rats and in a neurodevelopmental model of schizophrenia.

Authors:  Bernat Kocsis; Peia Lee; Richard Deth
Journal:  Brain Struct Funct       Date:  2013-07-10       Impact factor: 3.270

2.  A simultaneous [11C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism.

Authors:  Nicole R Zürcher; Erin C Walsh; Rachel D Phillips; Paul M Cernasov; Chieh-En J Tseng; Ayarah Dharanikota; Eric Smith; Zibo Li; Jessica L Kinard; Joshua C Bizzell; Rachel K Greene; Daniel Dillon; Diego A Pizzagalli; David Izquierdo-Garcia; Kinh Truong; David Lalush; Jacob M Hooker; Gabriel S Dichter
Journal:  Transl Psychiatry       Date:  2021-01-11       Impact factor: 6.222

Review 3.  Using Sibling Designs to Understand Neurodevelopmental Disorders: From Genes and Environments to Prevention Programming.

Authors:  Mark Wade; Heather Prime; Sheri Madigan
Journal:  Biomed Res Int       Date:  2015-07-15       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.